The goal of seamless enterprise-wide image access and distribution faces a major obstacle: Health Level 7 message incompatibility continues to constitute a technical barrier to broader PACS adoption in cardiology and orthopedics.
The goal of seamless enterprise-wide image access and distribution faces a major obstacle: Health Level 7 message incompatibility continues to constitute a technical barrier to broader PACS adoption in cardiology and orthopedics.
Conformance to standard HL7 message format is the ultimate bridge over this obstacle, but sources predict it will take years before vendors fully adopt a standard message format that achieves total cross-platform compatibility. As a result, many institutions use brokers to interface information systems and PACS.
"Current trends are moving to a brokerless environment, with PACS embedded with HL7 interfaces and informatics-PACS alliances developing elegant integrations. But this could take 10 years or more to achieve," said Chris Walker, CEO of the California-based Cardio-Vascular Sales.
What progress has been made has occurred at a slower pace than most clinicians would prefer.
Excluding digital cardiac cath labs, PACS has penetrated only about 10% of hospital cardiology departments, according to Walker. Radiology PACS, on the other hand, is present in over 50% of U.S. hospitals.
Jacques Cornet, a vice president at Cedara Software, cited several other challenges to broader cardiology PACS adoption:
Many technology vendors who currently offer clinical PACS in this area provide solutions that limit institutional connectivity as either cardiology PACS or radiology PACS - not as a seamless, integrated enterprise-wide system.
"This approach only serves to develop further information/image silos within the healthcare enterprise," Cornet said.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.